Medicaid investigation
Executive Summary
AstraZeneca says it has not received a subpoena related to Boston U.S. attorney's investigation of repackaging as a potential avenue to avoid Medicaid rebate payments. Prilosec is one of the products repackaged by Kaiser, which has been subpoenaed (1"The Pink Sheet" Nov. 6, p. 3)